The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krupitskiĭ E.M.

Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva

Zvartau É.É.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Tsoĭ-Podosenin M.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Masalov D.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Burakov A.M.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Egorova V.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Didenko T.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Romanova T.N.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Ivanova E.B.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Bespalov A.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Verbitskaia E.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Neznanov N.G.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Grinenko A.Ia.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

O’Braĭen Ch.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Vudi D.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial

Authors:

Krupitskiĭ E.M., Zvartau É.É., Tsoĭ-Podosenin M.V., Masalov D.V., Burakov A.M., Egorova V.Iu., Didenko T.Iu., Romanova T.N., Ivanova E.B., Bespalov A.Iu., Verbitskaia E.V., Neznanov N.G., Grinenko A.Ia., O’Braĭen Ch., Vudi D.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5‑2): 44‑54

Views: 2768

Downloaded: 28

Download PDF (RU)
Contact the author
Table of contents

NALTREXONE AND FLUOXETINE FOR MAINTENANCE OF REMISSION IN PATIENTS WITH HEROIN ADDICTION: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
NALTREXONE AND FLUOXETINE FOR MAINTENANCE OF REMISSION IN PATIENTS WITH HEROIN ADDICTION: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL

To cite this article:

Krupitskiĭ EM, Zvartau ÉÉ, Tsoĭ-Podosenin MV, et al. . Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5‑2):44‑54. (In Russ.)

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Effi­cacy and safety of choline alfo­scerate in the preventive therapy of deme­ntia in elde­rly patients with Mild Cognitive Impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):92-99
Traumatic damage to the diaphragm in children. Piro­gov Russian Journal of Surgery. 2024;(4):64-68
Promising approaches to the pathogenetic therapy of amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21
Long-term follow-up of adult patients with serial and status course of epileptic seizures. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):63-68
Use of systemic steroids in hospitalized patients with COVID-19. Russian Journal of Preventive Medi­cine. 2024;(5):75-80
Our expe­rience in the treatment of congenital nasal median hete­rotopias in children and an overview of various treatment tactics. Russian Bulletin of Otorhinolaryngology. 2024;(2):28-32
Clinical and anatomical rationale for the effe­ctiveness of treatment of phle­gmon of the floor of the oral cavity and deep cellular spaces of the neck complicated with sepsis. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(2):19-25
B vita­mins and diseases of the peri­pheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Expe­rience with the use of risdiplam in a fami­lial case of spinal muscular atro­phy 5q in patients with a homo­zygous dele­tion of the SMN1 gene and the same copy number of the SMN2 gene. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):138-141

Two hundreds and eighty patients with heroin addiction were randomized into 4 equal groups. Patients of the group 1 received naltrexone (N) in dosage 50 mg/day and fluoxetine (F) in dosage 20 mg/day during 6 months. Group 2 received N/F-placebo (FN), group 3 – N-placebo (NP)/F and group 4 – NP/FP. All patients underwent a session of individual psychotherapy for the maintenance of remission. Express urine drugs tests were used for remission control. Compliance was controlled by a riboflavin marker. Clinical state, psychiatric status and social functioning were assessed using quantified international scales and tests. To the end of the 6 month course, 43% of patients of group 1, 36% of group 2, 21% of group 3 and 10% of group 4 were in remission. Therefore, N/F was more effective than F/NP (p<0,01) and FP/NP (p<0,001); N/FP was more effective than F/NP (p<0,05) and NP/FP (p<0,001); F/NP did not differ significantly from NP/FP (p=0,1); N/F did not differ from N/FP (p=0,2). However N/ F was more effective compared to N/FP only in women, probably, due to the higher baseline levels of depression, anxiety and anhedonia. Naltrexone was superior to placebo and fluoxetine in the efficacy of maintenance of remission and preventing relapse in patients with heroin addiction. The combination of naltrexone and fluoxetine was more effective compared to the monotherapy with naltrexone in women only.

Keywords:

naltrexone,fluoxetine
heroin addiction
treatment

Authors:

Krupitskiĭ E.M.

Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva

Zvartau É.É.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Tsoĭ-Podosenin M.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Masalov D.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Burakov A.M.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Egorova V.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Didenko T.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Romanova T.N.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Ivanova E.B.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Bespalov A.Iu.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Verbitskaia E.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Neznanov N.G.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Grinenko A.Ia.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

O’Braĭen Ch.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

Vudi D.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova;
Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva;
fakul'tet psikhiatrii Universiteta shtata Pensil'vaniia (SShA)

List of references:

  1. Krupitskii E.M., Burakov A.M., Romanova T.N. i dr. Anketa dlya otsenki sindroma angedonii u detoksitsirovannykh bol'nykh opiinoi narkomaniei. Vopr narkol 2000;4:43-46.
  2. Beck A.T., Ward C.H., Mendelson M. et al. An inventory for measuring depression. Arch Gen Psychiat 1961;4:561-571.
  3. Carroll K.M., Ball S.A., Nick C. et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence - efficacy of contingency management and significant other involvement. Arch Gen Psychiat 2001;58:8:755-761.
  4. Cornish J.W., Metzger D., Woody G.E. et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Substance Abuse Treatment 1997;14:6:529-534.
  5. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSM-IV)/ Eds. A. Frances, H.A. Pincus, M.B. First. Substance Rel Dis 1994;175-272.
  6. Fals-Stewart W., O’Farrell T.J. Behavioral family counseling and naltrexone for male opioid-dependent patients. J Consult Clin Psychol 2003;71:3:432-442.
  7. Judson B.A., Carney T.M., Goldstein A. Naltrexone treatment of heroin addiction: Efficacy and safety in a double blind dosage comparison. Drug Alcohol Depend 1981;7:325-346.
  8. Kleber H., Kosten T., Gaspari J. Nontolerance to opioid antagonism of naltrexone. Biol Psychiat 1985;20:66-72.
  9. Krupitsky E.M., Burakov A.M., Romanova T.N. et al. The syndrome of anhedonia in recently detoxified heroin addicts: assessment and treatment: Abstracts of the International Meeting «Building International Research on Drug Abuse: Global Focus on Youth». Scottsdale, AZ: National Institute on Drug Abuse 1998;15.
  10. Krupitsky E.M., Burakov A.M., Didenko T.Y. et al. Effects of citalopram treatment of protracted withdrawal (syndrome of anhedonia) in patients with heroin addiction. Addictive Dis Their Treatment 2002;1:1:29-33.
  11. Krupitsky E., Zvartau E., Karandashova G. et al. The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med 2004;5:30-33.
  12. Krupitsky E.M., Zvartau E.E., Masalov D.V. et al. Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Substance Abuse Treatment 2004;26:285-294.
  13. Krupitsky E.M., Zvartau E.E., Lioznov D.A. et al. Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addiction Res 2006;12:12-19.
  14. Lerman C., Shieldsb P.G., Wileytoa E.P. et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002;12:627-634.
  15. McLellan A.T., Luborsky L., Cacciola J., Griffith J. New data from the Addiction Severity Index: Reliability and validity in three centers. J Nervous Mental Dis 1985;173:412-423.
  16. Merser D.E., Vudi Dzh. Individual'noe konsul'tirovanie narkozavisimykh. Per. s angl. Varshava 2001.
  17. Navaline H.A., Snider E.C., Petro C. et al. Preparations for AIDS Vaccine Trials. An Automated Version for the Risk Assessment Battery (RAB): Enhancing the Assessment of Risk Behaviors. AIDS Res Human Retroviruses 1994.
  18. O’Brien C.P., Greenstein R., Mintz J., Woody G.E. Clinical experience with naltrexone. Am J Drug Alc Abuse 1975;2:365-377.
  19. O’Brien C.P., Childress A.R., McLellan A.T. et al. Use of naltrexone to extinguish opioid conditioned responses. J Clin Psychiat 1984;45:8:Sec 2:53-56.
  20. O’Malley S.S., Jaffe A., Chang G. et al. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiat 1992;49:881-887.
  21. Oslin D.W., Berrettini W., Kranzler H.R. et al. A functional polymorphism of the µ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003;28:1546-1552.
  22. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
  23. Sobell L.C., Sobell M.B. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Measuring Alcohol Consumption. Eds. R. Litten, J. Allen. Human Press 1992.
  24. Spielberger C.D., Anton W.D., Bedell J. In: The nature and treatment of test anxiety. Emotion and Anxiety: New concepts, methods and applications. Eds. M. Zuckerman, C.D. Spielberger. Hillsdale. New York: Erlbaum 1976.
  25. Tennant F.S., Rawson R.A., Cohen A.I., Mann A. Clinical Experience with naltrexone in suburban opioid addicts. J Clin Psychiat 1984;45:9:42-45.
  26. Washton A.M., Pottash A.C., Gold M.S. Naltrexone in addicted business executives and physicians. J Clin Psychiat 1984;45:39-41.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.